DateThu, Feb 25, 2021, 12:00 PM – Thu, Feb 25, 2021, 01:00 PM
BONUS SPONSORED WEBINAR!
February 25, 2021
During the COVID-19 pandemic, there were notable differences in hospital-acquired infections (HAIs) and antimicrobial use, as both were reported in medical literature and public health venues. This webinar focuses on the observed surge capacity issues during the pandemic and summarize the available medical literature on HAIs and antimicrobial/diagnostic stewardship issues that were highlighted during the pandemic. The second half of the webinar focuses more on insights from key opinion leaders from two health care systems that discuss the changes in cross functional antimicrobial/diagnostic stewardship and infection prevention programs, which also affect administrative efforts in these regulated areas. Our speakers highlight process improvement areas and drug utilization and resistance issues that arise in surge capacity situations during a pandemic or yearly influenza seasons. Though given the unprecedented experiences, leadership and resiliency surfaced to the top to help drive change and process improvement.
- Review the HAI and resistance trends surrounding operational issues in antimicrobial and diagnostics use
- Learn about the COVID-19 impact on improving antibiotic stewardship program and infection prevention workflows and metrics
- Discuss resource optimization insights to protect both patients and health care workers
- Describe COVID-19 and future surge capacity planning for cold and flu season
- Kalvin Yu, MD, FIDSA
Medical Director of Medical Informatics, BD
- Rebekah Moehring, MD, MPH
Associate Professor of Medicine Duke Antimicrobial Stewardship Outreach Network (DASON), Duke Infection Control Outreach Network (DICON), Duke University Medical Center
- Edward A. Stenehjem, MD, MSc
Medical Director of Antimicrobial Stewardship and Associate Professor of Research, Intermountain Healthcare
- Nancy Myers, PhD (Moderator)
Vice President of Leadership and System Innovation, American Hospital Association